title: [The use of cycloferon in the combined treatment of tuberculosis patients infected with HIV and viral hepatitis].
abstract: The study was designed to evaluate efficiency of 8-week treatment of 86 patients with tuberculosis and concomitant mild hepatitis B using cycloferon tablets. This therapy had beneficial effect on the symptoms of intoxication syndrome and respiratory manifestations of tuberculosis; in addition, it improved hemograms. By the end of the treatment the frequency of sputum abacillation was 4.9 times and positive X-ray dynamics (cavity closure) 2.2 times higher than in control. Therapy positively influenced hepatic function assessed from activity of cytolitic enzymes and bilirubin level; also, it improved serum levels of total protein.
authors.forename: A K
authors.initials: AK
authors.lastname: Ivanov
authors.forename: A M
authors.initials: AM
authors.lastname: Panteleev
authors.forename: D S
authors.initials: DS
authors.lastname: Sukhanov
authors.forename: T V
authors.initials: TV
authors.lastname: Sologub
authors.forename: M G
authors.initials: MG
authors.lastname: Romanov
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000166:Acridines / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D015658:HIV Infections / Q000150:complications*; D006509:Hepatitis B / Q000150:complications*; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000166:Acridines; D007369:Interferon Inducers; C026430:10-carboxymethyl-9-acridanone